A process for the production of crystals with controlled surface
smoothness, size, shape and degree of crystallinity, compositions
comprising such crystals, and the use of certain crystals, especially
lactose, lactose monohydrate, fluticasone propionate, salmeterol
xinafoate, salbutamol sulphate or ipratropium bromide in pharmaceutical
compositions.
